Concepedia

L Xerri

LX

Statistics

Publications

9

Citations

738

H-Index

9

Active since

1982

Affiliations

VenatoRx Pharmaceuticals (United States)(Current)

University of North Texas Health Science Center

University of North Texas System

University of North Texas

University of Siena

L Xerri is an author at VenatoRx Pharmaceuticals (United States) specializing in medicine, clinical microbiology, and drug resistance.

Top concepts

Publications per year

1982–2021

9

Publications

9

Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections

Bin Liu, Robert E. Lee Trout, Guo‐Hua Chu et al. · Journal of Medicinal Chemistry · 2019 · 281 citations · Full text

VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in <i>Enterobacterales</i> and Pseudomonas aeruginosa

Jodie C. Hamrick, Jean‐Denis Docquier, Tsuyoshi Uehara et al. · Antimicrobial Agents and Chemotherapy · 2019 · 204 citations · Full text

In vitro activity of the tribactam GV104326 against gram-positive, gram-negative, and anaerobic bacteria

Enza Di Modugno, Isabelle Erbetti, Luc Ferrari et al. · Antimicrobial Agents and Chemotherapy · 1994 · 101 citations · Full text

, , +20

Discovery of VNRX-7145 (VNRX-5236 Etzadroxil): An Orally Bioavailable β-Lactamase Inhibitor for Enterobacterales Expressing Ambler Class A, C, and D Enzymes

Robert E. Lee Trout, Allison L. Zulli, Eugen F. Mesaros et al. · Journal of Medicinal Chemistry · 2021 · 41 citations · Full text

Ceftazidime in treatment of acute pulmonary exacerbations in patients with cystic fibrosis

Rita Padoan, A Brienza, Rosa Maria Crossignani et al. · The Journal of Pediatrics · 1983 · 36 citations

, , +3

1–5 of 9